MedAware Systems Releases Cross-Platform Post Market Product Monitoring Service

BOULDER, Colo. - May 6, 2021 - PRLog -- MedAware Systems announced the release today of its Science of Health Informatics (SOHInfo) cross-platform monitoring and surveillance management service. It is the industry's first AI-powered subscription application that provides continuous monitoring and analysis on reported Adverse Events, Published Scientific Literature, and major Social Media platforms - keeping round-the-clock vigilance of pharmaceutical and medical device products.

The Service delivers the most comprehensive view of reported events; continuously monitors leading literature repositories using custom AI to identify, retrieve and curate all available published science on products; and eliminates the need to spend hours weeding through countless posts, links, and comments to find relevant threads to identify and interpret potential problems.

Data are organized and displayed using intuitive, at-a-glance charts, either from SOHInfo's standard library or custom generated by users to group products by manufacturer, product code, or any other criteria within the data that they determine.

SOHInfo (www.sohinfo.com) supports both FDA and MDR post market vigilance requirements and delivers in-depth metrics and analysis of events for complete understanding of problems and causes. The Service comes with a free 30-day free trial.

"Our customers are saving considerable time, effort and cost with SOHInfo's comprehensive Cross-Platform Product Monitoring Service. It is easy to set up and use, providing deep intelligence through a single application" said Michael Willis, CEO. He continued: "Users are able to configure the Service to track areas critical to them for understanding how their products are performing in the real world."

ABOUT MEDAWARE SYSTEMS, INC.

MedAware Systems, Inc. is a next generation medical data company that empowers Pharma and Medical Device companies with all available evidence from published clinical trials research and Event reporting repositories. The Company utilizes a combination of Human and Artificial Intelligence to make the vast body of data instantly available and indispensable for fully understanding the safety and efficacy of medical treatments and devices.